GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Cash Flow from Operations

Nuvation Bio (Nuvation Bio) Cash Flow from Operations : $-44.71 Mil (TTM As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Sep. 2021, Nuvation Bio's Net Income From Continuing Operations was $-21.98 Mil. Its Depreciation, Depletion and Amortization was $0.07 Mil. Its Change In Working Capital was $4.89 Mil. Its cash flow from deferred tax was $0.00 Mil. Its Cash from Discontinued Operating Activities was $0.00 Mil. Its Asset Impairment Charge was $0.00 Mil. Its Stock Based Compensation was $2.75 Mil. And its Cash Flow from Others was $1.12 Mil. In all, Nuvation Bio's Cash Flow from Operations for the three months ended in Sep. 2021 was $-13.15 Mil.


Nuvation Bio Cash Flow from Operations Historical Data

The historical data trend for Nuvation Bio's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Cash Flow from Operations Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Cash Flow from Operations
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Cash Flow from Operations Get a 7-Day Free Trial - -14.73 -16.83 -13.15 -

Nuvation Bio Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Nuvation Bio's Cash Flow from Operations for the fiscal year that ended in Dec. 2020 is calculated as:

Nuvation Bio's Cash Flow from Operations for the quarter that ended in Sep. 2021 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-44.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Nuvation Bio's net income from continuing operations for the three months ended in Sep. 2021 was $-21.98 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Nuvation Bio's depreciation, depletion and amortization for the three months ended in Sep. 2021 was $0.07 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Nuvation Bio's change in working capital for the three months ended in Sep. 2021 was $4.89 Mil. It means Nuvation Bio's working capital increased by $4.89 Mil from Jun. 2021 to Sep. 2021 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Nuvation Bio's cash flow from deferred tax for the three months ended in Sep. 2021 was $0.00 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Nuvation Bio's cash from discontinued operating Activities for the three months ended in Sep. 2021 was $0.00 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Nuvation Bio's asset impairment charge for the three months ended in Sep. 2021 was $0.00 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Nuvation Bio's stock based compensation for the three months ended in Sep. 2021 was $2.75 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Nuvation Bio's cash flow from others for the three months ended in Sep. 2021 was $1.12 Mil.


Nuvation Bio Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.